Form 8.3 - [Allergan Plc]
30 Aprile 2020 - 3:47PM
UK Regulatory
TIDM0Y7T TIDM0QCV
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
--------------------------------------------- -------------------------------
Company dealt in Allergan plc
--------------------------------------------- -------------------------------
Class of relevant security to which US$0.0001 ordinary shares
the dealings being disclosed relate (Note 2)
--------------------------------------------- -------------------------------
Date of dealing 29(th) April 2020
--------------------------------------------- -------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
------------------------------------- -------------------- -----------
Number (%) Number (%)
------------------------------------- ---------- -------- ------ ---
(1) Relevant securities 14,139,097 4.29535%
------------------------------------- ---------- -------- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------- ---------- -------- ------ ---
(3) Options and agreements to
purchase/sell N/A
------------------------------------- ---------- -------- ------ ---
Total 14,139,097 4.29535%
------------------------------------- ---------- -------- ------ ---
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
------------------------------------------- ----------- -----------
Number (%) Number (%)
------------------------------------------- ------ --- ------ ---
(1) Relevant securities N/A
------------------------------------------- ------ --- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------------- ------ --- ------ ---
(3) Options and agreements to purchase/sell N/A
------------------------------------------- ------ --- ------ ---
Total N/A
------------------------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
-------------- ----------------------------- -----------------------
Purchase 300 189.29
-------------- ----------------------------- -----------------------
Purchase 100 187.54
-------------- ----------------------------- -----------------------
Purchase 225 189.29
-------------- ----------------------------- -----------------------
Purchase 23 189.29
-------------- ----------------------------- -----------------------
Purchase 130 189.29
-------------- ----------------------------- -----------------------
Purchase 200 189.29
-------------- ----------------------------- -----------------------
Purchase 118 189.29
-------------- ----------------------------- -----------------------
Sale 3,400 189.29
-------------- ----------------------------- -----------------------
Sale 1,400 189.29
-------------- ----------------------------- -----------------------
Sale 500 189.29
-------------- ----------------------------- -----------------------
Sale 6,600 189.29
-------------- ----------------------------- -----------------------
Sale 12,805 189.29
-------------- ----------------------------- -----------------------
Sale 10,166 189.29
-------------- ----------------------------- -----------------------
Sale 44 189.29
-------------- ----------------------------- -----------------------
Sale 1,200 189.29
-------------- ----------------------------- -----------------------
Sale 135 189.54
-------------- ----------------------------- -----------------------
Sale 123 189.29
-------------- ----------------------------- -----------------------
Transfer out (6,500) N/A
-------------- ----------------------------- -----------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
------------- --------------------- ----------------------------- --------------
N/A
------------- --------------------- ----------------------------- --------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money
e.g. call option purchasing securities to which price American, date paid/received
varying etc. the option relates European etc. per unit (Note 5)
(Note 7)
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
N/A
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
--------------------- ------- -------------------------
N/A
--------------------- ------- -------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-----------------------------------------------------------
N/A
-----------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
------------------------------------------------------- -----------------
Date of disclosure 30(th) April 2020
------------------------------------------------------- -----------------
Contact name Lionel Colaco
------------------------------------------------------- -----------------
Telephone number 020 33956098
------------------------------------------------------- -----------------
If a connected EFM, name of offeree/offeror with which N/A
connected
------------------------------------------------------- -----------------
If a connected EFM, state nature of connection (Note N/A
10)
------------------------------------------------------- -----------------
(END) Dow Jones Newswires
April 30, 2020 09:47 ET (13:47 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Grafico Azioni Abbvie (LSE:0QCV)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Abbvie (LSE:0QCV)
Storico
Da Mag 2023 a Mag 2024
